This inventor holds 1 USPTO granted patent. Top assignee: Innovstone Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhou Yin and a PRMT5-Inhibiting Anti-Tumor Compound.
Introduction
Zhou Yin is an inventor based in Shanghai, China, associated with Innovstone Therapeutics Limited. His patent work includes a compound designed to inhibit PRMT5, an enzyme linked to certain cancers and other diseases.
Latest Patents
Zhou Yin is named on 1 patent: “Compound Having Anti-Tumor Activity and Use Thereof.” The patent describes a compound with a structure represented by formula (I) and its use as a PRMT5 inhibitor. Reported experiments found inhibitory effects on PRMT5 enzyme activity and tumor-cell growth, suggesting potential for treating PRMT5-mediated diseases. The patent also describes a synthesis method intended to be straightforward to operate and suitable for large-scale industrial production.
Career Highlights
Zhou Yin’s listed patent reflects work at the intersection of medicinal chemistry and cancer research. Its focus is on developing a potential therapeutic compound and a practical method for producing it.
Collaborations
The patent lists Yunlong Song and Wenqing Xu among Zhou Yin’s coworkers. The available information identifies Innovstone Therapeutics Limited as his company.
Conclusion
Zhou Yin’s patent centers on a potential PRMT5-inhibiting compound, its anti-tumor activity, and a synthesis approach designed with industrial application in mind.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile